Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Actual shortage | 2024-02-22 | 2024-05-03 | 220261 |
| TEVA-METFORMIN | 850MG | TABLET | Actual shortage | 2024-02-22 | 2024-02-22 | 220264 |
| TEVA-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-02-22 | 2024-04-05 | 220267 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2024-02-29 | 2024-05-03 | 220977 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Actual shortage | 2024-02-29 | 2024-04-25 | 220980 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Actual shortage | 2024-02-29 | 2024-04-25 | 220983 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-02-29 | 2024-05-03 | 220986 |
| TEVA-TOPILENE | 0.05% | CREAM | Actual shortage | 2024-02-29 | 2024-04-11 | 220989 |
| TEVA-TOPISONE | 0.05% | CREAM | Actual shortage | 2024-02-29 | 2024-05-03 | 220992 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Actual shortage | 2024-03-07 | 2024-03-07 | 221531 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-05-03 | 221534 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Actual shortage | 2024-03-07 | 2024-03-28 | 221537 |
| TEVA-SUCRALFATE | 1G | TABLET | Actual shortage | 2024-03-07 | 2024-04-25 | 221540 |
| TEVA-DILTIAZEM XC | 360MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-07 | 2024-04-25 | 221546 |
| TEVA-METFORMIN | 850MG | TABLET | Actual shortage | 2024-03-07 | 2024-04-05 | 221549 |
| TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-03-07 | 2024-03-28 | 221552 |
| TEVA-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-03-07 | 2024-03-07 | 221567 |
| TEVA-TECNAL C 1/2 | 30MG 330MG 40MG 50MG | CAPSULE | Actual shortage | 2024-03-18 | 2024-05-03 | 222560 |
| TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-03-18 | 2024-03-21 | 222569 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-18 | 2024-03-21 | 222572 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |